Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer

NCT00868634 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: capecitabine
DRUG: bevacizumab
DRUG: capecitabine
DRUG: bevacizumab
DRUG: vinorelbine

Sponsor

iOMEDICO AG

Collaborators

[object Object]
[object Object]
[object Object]